May 3 | 2022

2cureX offentliggör årsredovisning för räkenskapsåret 2021

Read more
April 29 | 2022

Rättelse: Korrektion till “Kallelse till årsstämma i 2cureX AB” utfärdad den 21 april 2022

Read more
April 22 | 2022

Correction of “Notice of annual general meeting of 2cureX AB (publ)” issued on 21st April 2022

Read more
April 22 | 2022

Korrektion till “Kallelse till årsstämma i 2cureX AB” utfärdad den 21 april 2022

Read more
April 21 | 2022

Notice of annual general meeting of 2cureX AB (publ)

Read more
April 21 | 2022

Kallelse till årsstämma i 2cureX AB

Read more
March 14 | 2022

2cureX launches IndiTreat® mCRC Explore and completes portfolio rollout plan for 2022

Read more
February 24 | 2022

2cureX publishes interim report for the fourth quarter and all 12 months of 2021

Read more
February 24 | 2022

2cureX offentliggör delårsrapport för det fjärda kvartalen och alla tolv månader 2021

Read more
January 21 | 2022

New Institutional shareholder

Read more
January 11 | 2022

IndiTreat® to be distributed in Czech Republic and Slovakia through Promedica

Read more
January 5 | 2022

IndiTreat® to be distributed in Poland by Perlan Technologies

Read more
December 22 | 2021

First IndiTreat® order received from Labormed, Slovenia

Read more
December 16 | 2021

First hospital joins the IndiTreat® Evaluation Program IGNITE

Read more
December 14 | 2021

2cureX launches IndiTreat® mCRC Start test to guide 1st line treatment

Read more
December 13 | 2021

2cureX reaches the goals for the 2021 rollout plan

Read more
December 9 | 2021

2cureX signs yet another distribution agreement – this time with Omnigen Medical Products in Turkey

Read more
November 25 | 2021

2cureX offentliggör delårsrapport för det tredje kvartalet och första nio månader 2021

Read more